Publications
Detailed Information
Long-term Clinical Outcome of Helicobacter pylori-negative Gastric Mucosa-associated Lymphoid Tissue Lymphoma is Comparable to That of H. pylori-positive Lymphoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Su Jin | - |
dc.contributor.author | Kim, Joo Sung | - |
dc.contributor.author | Kim, Hansoo | - |
dc.contributor.author | Kim, Sang Gyun | - |
dc.contributor.author | Jung, Hyun Chae | - |
dc.contributor.author | Song, In Sung | - |
dc.contributor.author | Kim, Chul Woo | - |
dc.date.accessioned | 2012-05-31T01:37:57Z | - |
dc.date.available | 2012-05-31T01:37:57Z | - |
dc.date.issued | 2009-04 | - |
dc.identifier.citation | JOURNAL OF CLINICAL GASTROENTEROLOGY; Vol.43 4; 312-317 | ko_KR |
dc.identifier.issn | 0192-0790 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76648 | - |
dc.description.abstract | Goals and Background: Little is still known regarding the clinical features and prognosis of gastric mucosa-associated lymphoid tissue (MALT) lymphoma without Helicobacter pylori (H. pylori) infection. Study: From January 1996 to April 2006, a total of 185 patients with gastric MALT lymphoma were enrolled at Seoul National University Hospital. To assess the differences in clinical characteristics and long-term outcomes between H. pylori-negative (n = 29 15.7%) and H. pylori-positive (n = 156, 84.3%) cases, we compared these 2 types of lymphoma. Results: The overall median follow-up period was 39 months. There were no significant differences between the 2 groups in terms of age, macroscopic phenotype, or histologic grade. H. pylori-negative group showed male predominancy (72.4%) and higher percentage of proximal stomach location (62.1%). Although H. pylori-negative lymphomas were more frequently presented as advanced disease (stage HE or IV, 37.9%), no significant differences in both the overall complete response and overall survival rates were observed between the 2 groups. Conclusions: Our results suggest that H. pylori-negative gastric MALT lymphoma shows a favorable long-term outcome, which is comparable to that of H. pylori-positive lymphoma. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | ko_KR |
dc.subject | mucosa-associated lymphoid tissue lymphoma | ko_KR |
dc.subject | Helicobacter pylori-negative | ko_KR |
dc.subject | long-term outcome | ko_KR |
dc.subject | tumor location | ko_KR |
dc.title | Long-term Clinical Outcome of Helicobacter pylori-negative Gastric Mucosa-associated Lymphoid Tissue Lymphoma is Comparable to That of H. pylori-positive Lymphoma | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정수진 | - |
dc.contributor.AlternativeAuthor | 김주성 | - |
dc.contributor.AlternativeAuthor | 김한수 | - |
dc.contributor.AlternativeAuthor | 김상균 | - |
dc.contributor.AlternativeAuthor | 김철우 | - |
dc.contributor.AlternativeAuthor | 정현채 | - |
dc.contributor.AlternativeAuthor | 송인성 | - |
dc.citation.journaltitle | JOURNAL OF CLINICAL GASTROENTEROLOGY | - |
dc.description.citedreference | Kim JS, 2007, BRIT J CANCER, V96, P1324, DOI 10.1038/sj.bjc.6603708 | - |
dc.description.citedreference | Nakamura S, 2006, CANCER, V107, P2770, DOI 10.1002/cncr.22326 | - |
dc.description.citedreference | Du MQ, 2006, GUT, V55, P886, DOI 10.1136/gut.2004.061663 | - |
dc.description.citedreference | Raderer M, 2006, GUT, V55, P616, DOI 10.1136/gut.2005.083022 | - |
dc.description.citedreference | Akamatsu T, 2006, HELICOBACTER, V11, P86 | - |
dc.description.citedreference | Wundisch T, 2005, J CLIN ONCOL, V23, P8018, DOI 10.1200/JCO.2005.02.3903 | - |
dc.description.citedreference | Nakamura S, 2005, CANCER, V104, P532, DOI 10.1002/cncr.21152 | - |
dc.description.citedreference | Yoon SS, 2004, ANN SURG, V240, P28, DOI 10.1097/01.sla.0000129356.81281.0c | - |
dc.description.citedreference | Fischbach W, 2004, GUT, V53, P34 | - |
dc.description.citedreference | Tsang RW, 2003, J CLIN ONCOL, V21, P4157, DOI 10.1200/JCO.2003.06.085 | - |
dc.description.citedreference | Ye HT, 2003, BLOOD, V101, P2547, DOI 10.1182/blood-2002-10-3167 | - |
dc.description.citedreference | Liu HX, 2002, GASTROENTEROLOGY, V122, P1286, DOI 10.1053/gast.2002.33047 | - |
dc.description.citedreference | Starostik P, 2002, BLOOD, V99, P3 | - |
dc.description.citedreference | Ruskone-Fourmestraux A, 2001, GUT, V48, P297 | - |
dc.description.citedreference | Liu HX, 2001, LANCET, V357, P39 | - |
dc.description.citedreference | Papa A, 2000, J CLIN GASTROENTEROL, V31, P169 | - |
dc.description.citedreference | Morgner A, 2000, GASTROENTEROLOGY, V118, P821 | - |
dc.description.citedreference | Steinbach G, 1999, ANN INTERN MED, V131, P88 | - |
dc.description.citedreference | de Jong D, 1999, ANN ONCOL, V10, P275 | - |
dc.description.citedreference | Schechter NR, 1998, J CLIN ONCOL, V16, P1916 | - |
dc.description.citedreference | Wotherspoon AC, 1998, ANNU REV MED, V49, P289 | - |
dc.description.citedreference | Nakamura S, 1997, CANCER, V79, P3 | - |
dc.description.citedreference | Dixon MF, 1996, AM J SURG PATHOL, V20, P1161 | - |
dc.description.citedreference | MONTALBAN C, 1995, ANN ONCOL, V6, P355 | - |
dc.description.citedreference | PARSONNET J, 1994, NEW ENGL J MED, V330, P1267 | - |
dc.description.citedreference | WOTHERSPOON AC, 1993, LANCET, V342, P575 | - |
dc.description.citedreference | RADASZKIEWICZ T, 1992, GASTROENTEROLOGY, V102, P1628 | - |
dc.description.citedreference | COGLIATTI SB, 1991, GASTROENTEROLOGY, V101, P1159 | - |
dc.description.citedreference | NEGRINI R, 1991, GASTROENTEROLOGY, V101, P437 | - |
dc.description.citedreference | MUSSHOFF K, 1977, STRAHLENTHER ONKOL, V153, P218 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.